Topical therapy for osteoarthritis: clinical and pharmacologic perspectives (Q34971645)

5 August 2017

1 reference

title

Topical therapy for osteoarthritis: clinical and pharmacologic perspectives (English)

1 reference

5 August 2017

0 references

Roy Altman

1

1 reference

PubMed ID

19332972

5 August 2017

Robert L Barkin

series ordinal

2

1 reference

PubMed ID

19332972

5 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

5 August 2017

Postgraduate Medicine

1 reference

5 August 2017

121

1 reference

5 August 2017

2

1 reference

5 August 2017

139-147

1 reference

Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study)

5 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Osteoarthritis: epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Assessing the burden of disease in the United States using disability-adjusted life years

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

The longitudinal course of hand osteoarthritis in a male population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

The Knee Clinical Assessment Study-CAS(K). A prospective study of knee pain and knee osteoarthritis in the general population: baseline recruitment and retention at 18 months

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Update of ACR guidelines for osteoarthritis: role of the coxibs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Serum concentrations of salicylic acid following topically applied salicylate derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Potential dangers from topical preparations containing methyl salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Are one or two dangerous? Methyl salicylate exposure in toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

The risk of severe salicylate poisoning following the ingestion of topical medicaments or aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Potentiation of warfarin anticoagulation associated with topical methyl salicylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Systematic review of topical capsaicin for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Impact of persistent hip or knee pain on overall health status in elderly people: A longitudinal population study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

Prevalence of Symptomatic Hand Osteoarthritis and Its Impact on Functional Status among the Elderly: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1986

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.03.1986

1 reference

5 August 2017

1 reference

PubMed ID

19332972